{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:56:18Z","timestamp":1791262578915,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,5,16]],"date-time":"2008-05-16T00:00:00Z","timestamp":1210896000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1007\/s10549-008-0052-z","type":"journal-article","created":{"date-parts":[[2008,5,15]],"date-time":"2008-05-15T15:47:29Z","timestamp":1210866449000},"page":"51-55","source":"Crossref","is-referenced-by-count":31,"title":["Mutation analysis of BRIP1\/BACH1 in BRCA1\/BRCA2 negative Chinese women with early onset breast cancer or affected relatives"],"prefix":"10.1007","volume":"115","author":[{"given":"A-Yong","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Liang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Li","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Xi","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gen-Hong","family":"Di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun-Wei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Song","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Min","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Tao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Zhou","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Ming","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,5,16]]},"reference":[{"key":"52_CR1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ccr.2007.01.010","volume":"11","author":"T Walsh","year":"2007","unstructured":"Walsh T, King MC (2007) Ten genes for inherited breast cancer. Cancer Cell 11:103\u2013105","journal-title":"Cancer Cell"},{"key":"52_CR2","doi-asserted-by":"crossref","unstructured":"Li WF, Hu Z, Rao NY et al (2007) The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified. Breast Cancer Res Treat. doi: 10.1007\/s10549-007-9708-3 (in press)","DOI":"10.1007\/s10549-007-9708-3"},{"key":"52_CR3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0092-8674(01)00304-X","volume":"105","author":"SB Cantor","year":"2001","unstructured":"Cantor SB, Bell DW, Ganesan S et al (2001) A novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function. Cell 105:149\u2013160","journal-title":"Cell"},{"key":"52_CR4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ccr.2005.08.004","volume":"8","author":"R Litman","year":"2001","unstructured":"Litman R, Peng M, Jin Z et al (2001) BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ. Cancer Cell 8:255\u2013265","journal-title":"Cancer Cell"},{"key":"52_CR5","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/ng1627","volume":"37","author":"WL Bridge","year":"2001","unstructured":"Bridge WL, Vandenberg CJ, Franklin RJ et al (2001) The BRIP1 helicase functions independently of BRCA1 in the Fanconi anemia pathway for DNA crosslink repair. Nat Genet 37:953\u2013957","journal-title":"Nat Genet"},{"key":"52_CR6","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/ng1902","volume":"38","author":"S Seal","year":"2001","unstructured":"Seal S, Thompson D, Renwick A et al (2001) Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nat Genet 38:1239\u20131241","journal-title":"Nat Genet"},{"key":"52_CR7","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/ng1625","volume":"37","author":"M Levitus","year":"2005","unstructured":"Levitus M, Waisfisz Q, Godthelp BC et al (2005) The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J. Nat Genet 37:934\u2013935","journal-title":"Nat Genet"},{"key":"52_CR8","first-page":"486","volume":"60","author":"OM Serova","year":"1997","unstructured":"Serova OM, Mazoyer S, Puget N et al (1997) Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes? Am J Hum Genet 60:486\u2013495","journal-title":"Am J Hum Genet"},{"key":"52_CR9","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1093\/hmg\/6.13.2309","volume":"6","author":"P Vehmanen","year":"1997","unstructured":"Vehmanen P, Friedman LS, Eerola H et al (1997) Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes. Hum Mol Genet 6:2309\u20132315","journal-title":"Hum Mol Genet"},{"key":"52_CR10","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev.genet.32.1.95","volume":"32","author":"N Rahman","year":"1998","unstructured":"Rahman N, Stratton MR (1998) The genetics of breast cancer susceptibility. Annu Rev Genet 32:95\u2013121","journal-title":"Annu Rev Genet"},{"key":"52_CR11","doi-asserted-by":"crossref","first-page":"R1005","DOI":"10.1186\/bcr1336","volume":"7","author":"AG Lewis","year":"2005","unstructured":"Lewis AG, Flanagan J, Marsh A et al (2005) Mutation analysis of FANCD2, BRIP1\/BACH1, LMO4 and SFN in familial breast cancer. Breast Cancer Res 7:R1005\u2013R1016","journal-title":"Breast Cancer Res"},{"key":"52_CR12","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0959-8049(02)00498-7","volume":"39","author":"SM Karppinen","year":"2003","unstructured":"Karppinen SM, Vuosku J, Heikkinen K et al (2003) No evidence of involvement of germline BACH1 mutations in Finnish breast and ovarian cancer families. Eur J Cancer 39:366\u2013371","journal-title":"Eur J Cancer"},{"key":"52_CR13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/humu.10238","volume":"22","author":"JL Rutter","year":"2003","unstructured":"Rutter JL, Smith AM, D\u00e1vila MR et al (2003) Mutational analysis of the BRCA1-interacting genes ZNF350\/ZBRK1 and BRIP1\/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals. Hum Mutat 22:121\u2013128","journal-title":"Hum Mutat"},{"key":"52_CR14","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/ijc.10214","volume":"98","author":"L Luo","year":"2002","unstructured":"Luo L, Lei H, Du Q et al (2002) No mutations in the BACH1 gene in BRCA1 and BRCA2 negative breast-cancer families linked to 17q22. Int J Cancer 98:638\u2013639","journal-title":"Int J Cancer"},{"key":"52_CR15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2407-6-19","volume":"6","author":"P Vahteristo","year":"2006","unstructured":"Vahteristo P, Yliannala K, Tamminen A et al (2006) BACH1 Ser919Pro variant and breast cancer risk. BMC Cancer 6:19","journal-title":"BMC Cancer"},{"key":"52_CR16","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1126\/science.1088753","volume":"302","author":"X Yu","year":"2003","unstructured":"Yu X, Chini CC, He M et al (2003) The BRCT domain is a phospho-protein binding domain. Science 302:639\u2013642","journal-title":"Science"},{"key":"52_CR17","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s004390100500","volume":"108","author":"B Klein","year":"2001","unstructured":"Klein B, Weirich G, Brauch H (2001) DHPLC-based germline mutation screening in the analysis of the VHL tumor suppressor gene: usefulness and limitations. Hum Genet 108:376\u2013384","journal-title":"Hum Genet"},{"key":"52_CR18","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/humu.1130","volume":"17","author":"W Xiao","year":"2001","unstructured":"Xiao W, Oefner PJ (2001) Denaturing high-performance liquid chromatography: a review. Hum Mutat 17:439\u2013474","journal-title":"Hum Mutat"},{"key":"52_CR19","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00432-006-0105-9","volume":"32","author":"CG Song","year":"2006","unstructured":"Song CG, Hu Z, Wu J et al (2006) The prevalence of BRCA1 and BRCA2 mutations in eastern Chinese women with breast cancer. J Cancer Res Clin Oncol 32:617\u2013626","journal-title":"J Cancer Res Clin Oncol"},{"key":"52_CR20","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/humu.9156","volume":"22","author":"Z Hu","year":"2003","unstructured":"Hu Z, Wu J, Liu CH et al (2003) The analysis of BRCA1 mutations in eastern Chinese patients with early onset breast cancer and affected relatives. Hum Mutat 22:104","journal-title":"Hum Mutat"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-008-0052-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-008-0052-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-008-0052-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T16:28:58Z","timestamp":1559233738000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-008-0052-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,16]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["52"],"URL":"https:\/\/doi.org\/10.1007\/s10549-008-0052-z","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5,16]]}}}